: iStockAnalyst.com Symbols Feed

Invest In HealthCare!

Tue, 01 Dec 2009 16:52:08 GMT

In 3 of the past 4 market rebounds since 1982, equity gains slowed to a single digit pace in the 2nd year, after the initial rally. Now dividend stocks have extra appeal because they offer a tempting alternative to CDs which pay virtually no interest at all, and long term bonds which pay a little bit more but leave you at the mercy of inflation. Established value companies in stable industries have usually proven a better long-term investment. Before S&P cut Pfizer (PFE) ratings to 'AA' from 'AAA' on Oct 16, 2009, there were 5 companies with AAA credit ratings: Automated Data Processing (ADP), Johnson & Johnson (JNJ), ExxonMobil (XOM) and Microsoft (MSFT). In other words, 2 out of 5 were healthcare companies.[More...]

Diabetes Care: Global Investing Opportunities

Mon, 23 Nov 2009 03:23:59 GMT

The American Diabetes Association estimates that there are currently 23.6 million diabetics in the U.S. (7.8% of the total population, including 17.9 million diagnosed cases, 5.7 million undiagnosed, and 57 million pre-diabetics. Diabetes results in an estimated $174 billion in costs from diagnosed cases of diabetes in the U.S. (2007).[More...]

Epinex Diagnostics: A New Paradigm For Diabetic Testing

Thu, 19 Nov 2009 15:19:29 GMT

Epinex Diagnostics Inc. (click on preceding link for the Company's News Room page) is a private company that is dedicated to the development of innovative point-of-care technologies using rapid diagnostic tests. Epinex has developed a proprietary platform for rapid tests that apply existing immunoassay strips and biosensors to create unique quantitative diagnostic tests.[More...]

A Winning Investment Strategy

Wed, 18 Nov 2009 15:39:58 GMT

We all want to succeed in everything that we do, including investing in the stock market. Though I have no analytical data to back it up, I am convinced that most people will lose money in the stock market over their lifetime. So why do so few people succeed at investing? Could it be that an individual's desire to succeed be a significant reason for their failure.[More...]

7 Dividend Stocks To Slay The Wall Street Giants

Wed, 11 Nov 2009 15:37:15 GMT

Driven by computers that cost more than the average person will earn in their lifetime the investment markets move at light speed. To keep pace hedge funds, mutual funds, institutional investors and multi-billion dollar money managers spend large sums of money on high-tech tools to give them an edge. Throw in some illegal insider trading from big names in the industry and it leaves you wondering what chance does a small individual investor have.[More...]

Big Pharma And Biotech - Industry Outlook

Mon, 09 Nov 2009 21:58:02 GMT

The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts. The next five years are expected to reflect a significant imbalance between new product introductions and patent losses.[More...]

American Jobs Disappear While The Stock Market Is Surging

Mon, 26 Oct 2009 21:33:01 GMT

Wall Street and Main Streets gap has never been wider. Yet investors are enjoying a vibrant market while the unemployed are enjoying long lines at their local unemployment office. To them the recession hits home and it hits home hard.[More...]

Abbott Laboratories (ABT) Dividend Stock Analysis

Mon, 26 Oct 2009 16:38:37 GMT

ABT is trading at a discount to 1.) and 3.) above. The stock is trading at a 21.9% premium to its calculated fair value of $42.18. ABT did not earn any Stars in this section.[More...]

BioCurex Poised For Positive Future Based On Results (OTC:BOCX)

Mon, 26 Oct 2009 16:12:10 GMT

BioCurex, Inc. (“BioCurex” or “the Company”) is a biotechnology company developing products for cancerdiagnosis, imaging, and therapy that target a global oncology market forecast to reach over $50 billion by 2009.[More...]

8 Dividend Stocks With The Right Stuff

Wed, 21 Oct 2009 16:56:18 GMT

What makes a good dividend stock? Every dividend growth investor is looking for a stock that will increase its dividend each and every year at a rate that makes the stock a better investment than fixed income alternatives. I have found that stocks that are able to do this share some common characteristics.[More...]

Beware, many stolen computers have tracking software

Mon, 09 Nov 2009 22:52:00 GMT

Nov. 9--LAWRENCE -- At $250, the laptop computer purchased on the street appeared to be a good deal.
But when officers showed up at Aileen Acevedo's Brook Street home with a search warrant seeking the computer a few nights later, she learned it was stolen from Lahey Clinic in Burlington, police said.
As with most computers being manufactured now, the Fujitsu Tablet laptop was equipped with tracking software which can pinpoint a stolen computer to any address.

: iStockAnalyst.com Symbols Feed

Invest In HealthCare!

Diabetes Care: Global Investing Opportunities

Epinex Diagnostics: A New Paradigm For Diabetic Testing

A Winning Investment Strategy

7 Dividend Stocks To Slay The Wall Street Giants

Big Pharma And Biotech - Industry Outlook

American Jobs Disappear While The Stock Market Is Surging

Abbott Laboratories (ABT) Dividend Stock Analysis

BioCurex Poised For Positive Future Based On Results (OTC:BOCX)

8 Dividend Stocks With The Right Stuff

Beware, many stolen computers have tracking software

Beware, Many Stolen Computers Have Tracking Software

Boston Scientific returns to profit in 3rd qtr

Sliding Dollar May Be Something to Cheer About

Abbott Reports Earnings Gain on Stronger Sales, Settlement of Patent Suit: W.W. Grainger Reports Revenue Continues to Fall

Abbott Profit Up 37% on Patent Settlement, Humira Sales

Humira and nutrition sales lift Abbott 3Q profit

St. Louis Post-Dispatch, David Nicklaus Column

Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth

Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth

Health Discovery Corporation Appoints Tom Gallagher, Former Wall Street Attorney& a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies

Morgan Joseph Names Bruce D. Jackson a Senior Vice President in Equity Research Covering the Medical Device Industry

PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain

Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets

Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio

Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy

Medtronic Reports First Quarter Revenue of $3.9 Billion

Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent

Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market

StreetSmart Strategies®, a Management Consulting Firm, Retains Veteran Corporate Investor Relations Officer David Prichard

Form 4 ABBOTT LABORATORIES For: Nov 24 Filed by: Mason Heather L (10K)

Form 4 ABBOTT LABORATORIES For: Oct 01 Filed by: WHITE MILES D (10K)

Form 4 ABBOTT LABORATORIES For: Nov 18 Filed by: Fussell Stephen R (10K)

Form 4 ABBOTT LABORATORIES For: Nov 12 Filed by: Bohuon Olivier (10K)

Form 4 ABBOTT LABORATORIES For: Oct 22 Filed by: Landgraf John C (10K)

Form 4 ABBOTT LABORATORIES For: Nov 11 Filed by: FREYMAN THOMAS C (10K)

Form 4 ABBOTT LABORATORIES For: Nov 11 Filed by: Mason Heather L (10K)

Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: ALBAN CARLOS (10K)

Form 4 ABBOTT LABORATORIES For: Nov 02 Filed by: Mason Heather L (10K)

Form 4 ABBOTT LABORATORIES For: Oct 20 Filed by: Warmuth Michael J (10K)